Trova

Study details better outcomes for Omicron BA.2 patients — Harvard Gazette

4.9 (755) · € 23.00 · In Magazzino

Study details better outcomes for Omicron BA.2 patients — Harvard Gazette
Harvard scientists keep close watch on Omicron subvariant

Harvard scientists keep close watch on Omicron subvariant

IJMS, Free Full-Text

IJMS, Free Full-Text

Associations of COVID-19 symptoms with omicron subvariants BA.2

Associations of COVID-19 symptoms with omicron subvariants BA.2

Comparative analysis of the risks of hospitalisation and death

Comparative analysis of the risks of hospitalisation and death

Long COVID following Omicron wave in Eastern India—A retrospective

Long COVID following Omicron wave in Eastern India—A retrospective

Infection with Omicron sub-lineage BA.1 protects from reinfection

Infection with Omicron sub-lineage BA.1 protects from reinfection

Clinical characteristics and vaccine effectiveness against SARS

Clinical characteristics and vaccine effectiveness against SARS

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron

Covid: Transmissibility, severity, reinfection of Omicron BA.2

Covid: Transmissibility, severity, reinfection of Omicron BA.2

Short-course early outpatient remdesivir prevents severe disease

Short-course early outpatient remdesivir prevents severe disease

Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on

Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on